Q32 Bio (QTTB) Revenue Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) Revenue Growth (1y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
-269.58% |
| Sep 30, 2023 |
131.80% |
| Jun 30, 2023 |
299.63% |
| Mar 31, 2023 |
267.46% |
| Dec 31, 2022 |
0.00% |
| Sep 30, 2022 |
-52.18% |
| Jun 30, 2022 |
-63.33% |
| Mar 31, 2022 |
-97.26% |
| Dec 31, 2021 |
-18.16% |
| Sep 30, 2021 |
195.77% |
| Jun 30, 2021 |
285.71% |
| Mar 31, 2021 |
4,883.84% |
| Dec 31, 2020 |
74.07% |
| Sep 30, 2020 |
28.57% |
| Jun 30, 2020 |
44.64% |
| Mar 31, 2020 |
117.78% |
| Dec 31, 2019 |
-52.93% |
| Sep 30, 2019 |
-72.47% |
| Jun 30, 2019 |
-71.90% |
| Mar 31, 2019 |
-76.09% |
